- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged a senior employee’s LinkedIn ‘Experience’ section promoted Enhertu to the public and off-label, using terms like “blockbuster” and “new”. Panel…
PMCPA found Cipla failed to evidence records of representative interactions with HCPs for nearly two years (Aug 2022–Jul 2024), breaching Clause 5.1…
GSK was found in breach of Clause 25.3 twice after sponsorship of a healthcare organisation’s conference was not clearly acknowledged from the…
A PCT pharmacist alleged a Teva-supported supplement about switching to CFC-free beclometasone inhalers was disguised promotion for Qvar. The Panel ruled Teva’s…
Two websites promoted unlicensed N-carbamyl-L-glutamic acid and anhydrous betaine powders with therapeutic indications and dosing information. The Panel ruled this amounted to…
Anonymous complainants alleged inappropriate hospitality at a psychiatrists’ meeting sponsored by Bristol-Myers Squibb and Otsuka. The Panel found the meeting’s purpose was…
A nurse alleged misleading claims about Ferinject dosing and safety at a Syner-Med exhibition stand and in a detail aid. The Panel…
An anaesthetist complained that a Bayer Schering Pharma advert in The Economist promoted a prescription-only MS medicine to the public and raised…
A health professional received an unsolicited email about Gilead’s UK and Ireland Fellowship Programme and queried how his private address was obtained…
A dispensing account manager sent an unapproved promotional Crestor email with inaccurate dosing and exaggerated efficacy/tolerability claims, plus unapproved slides and no…
A Xeomin leavepiece used a true “free from complexing proteins” fact alongside a horse chestnut visual, implying an unproven clinical advantage and…
Anonymous complaint alleged inappropriate entertainment/hospitality, biased sponsorship of fertility nurses, and suspected off-label selling of Pergoveris. PMCPA ruled no breach of Clauses…
A pharmacist said Sanofi-Aventis didn’t fulfil a reply-paid card request for Acomplia studies and promotional items. Company said it never received the…
A psychiatrist complained that a Janssen-Cilag presentation implied Risperdal Consta had neuroprotective effects. The PMCPA found the material misleading, unsubstantiated, and that…
Anonymous GP alleged a 5-star exhibition/learning centre venue and travel distance made a GP dermatology meeting inappropriate. Panel found the venue and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.